NeuroMetrix Reports that the Quell Health Cloud Has Collected Over 1 Million Hours of Quell Therapy and Health Data

WALTHAM, Mass.–(BUSINESS WIRE)–NeuroMetrix, Inc. (NASDAQ:NURO) announced a major milestone with over 1
million hours of Quell^® therapy and health data uploaded to
the Quell Health Cloud as of August 1, 2016. Quell is a wearable
therapeutic technology that provides drug-free relief from chronic pain
and is available without a prescription. The device communicates with a
smartphone app that provides objective feedback to the user about their
therapy utilization, sleep characteristics and activity levels. This
data is securely backed up to the Quell Health Cloud. Novel insights
from an analysis of this data include:

• Quell is used 6 hours a day, on average. This intensive level of
  utilization is expected given that Quell is often used to help manage
  moderate to severe chronic pain such as low back pain, nerve pain,
  arthritic pain, and fibromyalgia.
• The majority of people with chronic pain suffer from low quality sleep
  and 71% of Quell owners have used their device while sleeping. Quell
  has unique features that help control chronic pain while sleeping.
  About 38% of Quell therapy is delivered between the hours of 8 PM and
  8 AM. Quell users sleep an average of 6.6 hours per night, which is
  close to the minimum of 7 hours recommended by the American Academy of
  Sleep Medicine (AASM) for promotion of optimal health and reduced
  levels of pain.
• The Quell Health Cloud data also exposes challenges experienced by
  those with chronic pain. Nearly 40% of Quell users average less than 6
  hours of sleep. About 27% of users have a high number of periodic leg
  movements, which may disrupt sleep and is a risk factor for
  cardiovascular disease.
• People suffering from chronic pain often have reduced levels of
  activity, which further increases their pain and elevates their risk
  of obesity and heart disease among other chronic conditions. Quell is
  designed to promote activity by providing pain relief while engaging
  in activities. Encouragingly, users wearing Quell for at least 4 hours
  during daytime hours walk an average of 34 minutes per day with their
  device. This meets the American Heart Association (AHA)
  recommendations for physical activity in adults.

“One million hours of therapy data uploaded to the Quell Health Cloud is
an important milestone in our effort to develop Quell as a digital
health intervention for chronic pain. The Quell Health Cloud, already
one of the largest chronic pain databases in the world, is growing
rapidly as our customers create accounts to realize its value in helping
them manage their chronic pain,” said Shai N. Gozani, M.D., Ph.D.,
President and Chief Executive Officer of NeuroMetrix. “We have only
started mining the data. We believe that the Quell Health Cloud will
eventually provide our customers with real-time guidance to help
optimize their Quell therapy and more generally to reduce their chronic
pain. This data is also valuable for better understanding chronic pain
at a population level.”
About Quell Wearable Pain Relief Technology
Quell is FDA cleared and designed for the millions of people suffering
from chronic pain. The advanced wearable technology delivers 100% drug
free relief and is available without a prescription. Quell can be used
during the day while active, and at night while sleeping. Quell gives
users the option to start, stop, and adjust therapy discreetly via their
smartphone. It also provides therapy utilization and advanced sleep
tracking. Quell is available at select healthcare professionals and
retailers. To find a Quell retailer, visit the Store
Locator at QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.